Disease | iga nephropathy |
Comorbidity | C0033687|proteinuria |
Sentences | 18 |
PubMedID- 24721885 | Conclusions: the findings in this cohort and previous studies suggest that rare cases of mild iga nephropathy with nephrotic range proteinuria exhibit a clinical presentation, biopsy findings, treatment response, and outcome more typical of iga nephropathy with superimposed minimal change disease. |
PubMedID- 26239462 | Urinary ngal levels also correlated with the degree of proteinuria in patients with iga nephropathy [16] and membranous nephropathy [14,15]. |
PubMedID- 21533280 | Recently, cheng's review [46] illustrated that glucocoticoids significantly induced a protection of renal function and a reduction of proteinuria in patients with iga nephropathy. |
PubMedID- 23977072 | Discussed, the course of iga nephropathy with initial proteinuria <1 g/day is variable according to the change of proteinuria during the follow-up period [27]. |
PubMedID- 23331443 | Conclusion: for early iga nephropathy patients with minimal proteinuria, normal blood pressure, and normal renal function, treatment with 2.5 mg/daily of ramipril for 5 years does not offer any benefit. |
PubMedID- 22019331 | Conclusions: the addition of calcitriol to a renin-angiotensin system inhibitor resulted in a safe decrease in proteinuria in patients with iga nephropathy. |
PubMedID- 20826744 | Conclusions: among patients with primary glomerulopathy and nephrotic-range proteinuria, normoalbuminaemia is associated with iga nephropathy. |
PubMedID- 24707402 | Before the eradication therapy the mean proteinuria of patients with mn, iga nephropathy and fsgs were 2.42 +/- 3.24 g/day, 2.12 +/- 1.63 g/day and 1.80 +/- 1.32 g/day, respectively. |
PubMedID- 20594038 | The authors measured the extent of foot process effacement in 100 iga nephropathy cases with proteinuria and correlated it with the amount of proteinuria. |
PubMedID- 23197956 | Successful treatment of adult iga nephropathy with nephrotic-level proteinuria by combination therapy including long-term coadministration of mizoribine. |
PubMedID- 23557791 | Aims: both steroid pulse (sp) monotherapy and the combination of tonsillectomy and sp therapy (tsp) are effective for achieving clinical remission (cr), defined as negative hematuria and proteinuria, in patients with iga nephropathy (igan). |
PubMedID- 22456060 | Some iga nephropathy (igan) patients with massive proteinuria showed resistance to steroids and/or cytotoxic immunosuppressants based on the supportive therapy with renin- angiotensin system blockade. |
PubMedID- 23049672 | Oral calcitriol treatment reduced proteinuria in patients with iga nephropathy [172]. |
PubMedID- 20843592 | Conclusions: thujone-free wormwood with its favorable safety profile can be an alternative supplement to manage proteinuria in patients with iga nephropathy. |
PubMedID- 24131475 | Conclusion: immunoglobulin a nephropathy patients with lower proteinuria had higher galnac exposure rates. |
PubMedID- 21655166 | [2122] the ii genotype has been reported to be associated with more favorable prognosis and decreased proteinuria in patients with iga nephropathy. |
PubMedID- 23713873 | Calcitriol (0.5 microg calcitriol twice per week) has been effective in decreasing proteinuria in patients with iga nephropathy. |
PubMedID- 26289088 | Background: sometimes, acute and progressive proteinuria increases occur in patients with iga nephropathy (igan) after favorable long-term clinical courses of >10 years, but their clinical and histological characteristics are not well understood. |
Page: 1